Member Info for Vander

Is that the one where cows were walking on the airstrip? It would suit wsg down to the ground to sort it out for them They need to put PFs offer for university fees behind them - behind the scenes politics

Joe last xmas was not traditional. PF provided a great pre xmas present for some. I realise that we are still primarily shareholders in a west African oil scam- sorry a west African security business, but the current contract negotiations do seem credible. I realise WSG have a reputation for non delivery but surely a signed contract kept on hold represents a different problem to non-execution/ lack of initiative

How many vans do they have? I know that parking can be difficult in Northamptonshire I prefer it when you guys talk about trump and big contracts

Btw simpler areas, but less lucrative

Does anyone know of other European companies in a similar or more advanced position than wsg in setting up business in Iran post may sanctions news Wsg will not be the first to make in roads I presume. There a simpler areas than large airport security

Big phew......we needed that rns. Things are looking uo

It’s gone up 6p Wait to see SP post medimmune deal

Some of you guys may go up the rollercoaster twice- lucky —-. What’s happened to taffevans? And his £150k profit

One concern is that if they are co developing an optimised version of nuvec with medimmune, wouldn’tbe better using that version with UOA?

Following the medimmune rns, we should hope phase 1 of UoA to be positive. For the first time, this will allow nuvec to be used in a dna vaccine development programme It should work synergistically with cytolytic dna by enhancing its delivery in addition to that of the dna- encoding antigen Of note NT seemed to describe a Gowan’s type dna vaccine at the end of his presentation in nov 2017 in the q and a section ie intradermal delivery with a time dependent response. Ie planned well in advance

Blast predictive text

Sorry chatty. Maybe charity also applies

Thanks charity. I presume you have chosen 12p as that is when some will have doubled their money?

I think a few of us were banging on about it, but no one listened initially

The last peak was driven by nuvec news but collapsed due to sildenafil. we were relying on N4ps good judgement regarding sildenafil and it wasn’t to be. It would have been wise to sell based on probabilities but it is a hindsight judgement The odds were against them- uni of Bradford technology succeeding where Pfizer had previously failed since 1998, to optimise the pharmacokinetics of its blockbuster This time medimmune have assessed nuvec over 9 months and are buying into the technology- theSP does not reflect this imho A collaborationdeal will depend on a optimised/ co- developed version should be achievable given medi’ s world leading resources and experience in this area. There are benefits of the manufacturing patent which must attract them This could be bigger than we all realise. NT may be more humble on his next video outing but should give us a realistic clue to future valuation

The next step up is with the UoA update

Thanks leister for your estimates. Presumably a partially co developed product would mean medimmune would own some of the IP? And a share of its value- maybe a good thing Would an agreement entail upfront and milestone payments. Royalties seem a long way off though if they use it for the HPV vaccine less far away Presumably a deal would be less than the takeover value?

We were gutted also Hugh Although Pharma have to let duds “fail fast” The only positive of keeping it going was to reduce SP volatility. However it only delayed the inevitable Incidentally Can I check- how was the nuvec technology chosen. Was NT involved or did he inherit it?

Marineville I understand that if you were fully invested in the sildenafil story that it is hard to regain trust in N4p. The difference this time is that they have external validation. It is hard to get onto the Eu ncl programme. In 2016 only 2 of 18 applicants managed it. Also it is hard to get a co-development project on an optimised product and subsequent commercial deal unless the product is compelling I think some believe that a collaboration will not happen given the sidenafil fiasco. However they have been working with medimmune for 9 months and in my opinion this will become long term. Medimmune would not bother otherwise

The world is big but they all deal in dollars. Maybe I am wrong?